Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001384101-17-000046
Filing Date
2017-06-07
Accepted
2017-06-07 17:29:15
Documents
1
Period of Report
2017-06-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_149687093897005.html 4  
1 FORM 4 wf-form4_149687093897005.xml 4 4038
  Complete submission text file 0001384101-17-000046.txt   5707
Mailing Address C/O ARENA PHARMACEUTICALS, INC. 6166 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address
Nova Tina Susan (Reporting) CIK: 0001302605 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36156 | Film No.: 17898137

Mailing Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 243-6300
VERACYTE, INC. (Issuer) CIK: 0001384101 (see all company filings)

EIN.: 205455398 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories